Nexus Clinical Research (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.16 Cr
- Revenue Growth %
- Profit Growth 37.47%
- Ebitda 88.28%
- Net Worth -14.70%
- Total Assets -12.78%
About Nexus Clinical Research (India)
Nexus Clinical Research (India) Limited (NCRIL) is a Public Limited Indian Non-Government Company incorporated in India on 22 November 2005 and has a history of 19 years and five months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Nexus Clinical Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.16 Cr.
Meghna Bhatt, Amit Bhatt, and Amol Ghate serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U99999MH2005PLC157715
- Company No.
157715
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Nexus Clinical Research (India) Limited
Explore comprehensive data for Nexus Clinical Research (India) Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Nexus Clinical Research (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meghna Bhatt  | Director | 01-Dec-2005 | Current |
| Amit Bhatt | Director | 15-Dec-2018 | Current |
| Amol Ghate | Additional Director | 04-Jul-2017 | Current |
Financial Performance of Nexus Clinical Research (India).
Nexus Clinical Research (India) Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.47% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Clinical Research (India)?
In 2023, Nexus Clinical Research (India) had a promoter holding of 99.79% and a public holding of 0.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nexus Central Lab Services Private Limited
Meghna Bhatt and Amit Bhatt are mutual person
Optimal Health India Private LimitedMeghna Bhatt and Amit Bhatt are mutual person
- Nexus Medquest India Private Limited
Amit Bhatt and Amol Ghate are mutual person
Charges (Loans)
Open Charges
₹31.60 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.11 Cr
- Dewan Housing Finance Corporation Limited : 1.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Sep 2018 | Others | ₹2.11 Cr | Open |
| 27 May 2015 | Dewan Housing Finance Corporation Limited | ₹1.05 Cr | Open |
How Many Employees Work at Nexus Clinical Research (India)?
Unlock and access historical data on people associated with Nexus Clinical Research (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexus Clinical Research (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Clinical Research (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nexus Clinical Research (India)
Recent activity within the organization
- Annual General Meeting
Nexus Clinical Research (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nexus Clinical Research (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Amit Bhatt was appointed as a Director was appointed as a Director on 15 Dec 2018 & has been associated with this company since 6 years 5 months .
- Charges
A charge with Others amounted to Rs. 21.05 M with Charge ID 100203864 was registered on 11 Sep 2018.
- Director Appointment
Amol Jagahnathrao Ghate was appointed as a Additional Director was appointed as a Additional Director on 04 Jul 2017 & has been associated with this company since 7 years 10 months .
- Charges
A charge with Dewan Housing Finance Corporation Limited amounted to Rs. 10.55 M with Charge ID 10582815 was registered on 27 May 2015.
Frequently asked questions
What is the Incorporation or founding date of Nexus Clinical Research (India) Limited?
Nexus Clinical Research (India) Limited was incorporated on 22 Nov 2005.
What is authorized share capital and paid-up capital of Nexus Clinical Research (India) Limited?
The authorized share capital of Nexus Clinical Research (India) Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Nexus Clinical Research (India) Limited?
Currently 3 directors are associated with Nexus Clinical Research (India) Limited.
- Meghna Amit Bhatt
- Amit Bhatt
- Amol Jagahnathrao Ghate
What is the registered address of Nexus Clinical Research (India) Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nexus Clinical Research (India) Limited is Anuj Plot No. 45 1St Floor Mumbai-Pune Highway Sector-13, Nerul(E) India, Navi Mumbai, Maharashtra, 400706.
What is the corporate identification number (CIN) and company number of Nexus Clinical Research (India) Limited?
The corporate identification number (CIN) of Nexus Clinical Research (India) Limited is U99999MH2005PLC157715 and the company number is 157715 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nexus Clinical Research (India) Limited?
The Official website of Nexus Clinical Research (India) Limited is https://www.nexuscro.com
What change has been observed in the net worth of Nexus Clinical Research (India) Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Nexus Clinical Research (India) Limited has experienced an downturn of -14.70%.
What are the total open charges for Nexus Clinical Research (India) Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Nexus Clinical Research (India) Limited amount to ₹ 3.16 Cr.
When was the last Balance Sheet of Nexus Clinical Research (India) Limited filed with the ROC?
The most recent Balance Sheet for Nexus Clinical Research (India) Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
AB
Amit BhattDirectorTB
Tej BhatDirector
Similar Companies Based on Pharma Contract R&D
Watson Pharma Private Limited Mumbai, Maharashtra, India
Fortrea Development India Private Limited Bangaluru, Karnataka, India
Jubilant Biosys Limited Gautam Buddha Nagar, Uttar Pradesh, India
Aragen Life Sciences Limited Rangareddy, Telangana, India
Amneal Pharmaceuticals Private Limited Ahmedabad, Gujarat, India
Medreich Limited Bangaluru, Karnataka, India
Aether Industries Limited Surat, Gujarat, India